Depemokimab

Exdensur

100 MG / 1 ML SolutionCanadaMarketedAuthorised 17 Jul 2026

In other countries

The same active substances on other registers, the same brand first.

Exdensur 100 MG Solucion Inyectable en Pluma PrecargadaSpain · 100 mg/ml · solución inyectable en pluma precargada · Glaxosmithkline Trading Services LimitedSame brand
Exdensur 100 MG Solucion Inyectable en Jeringa PrecargadaSpain · 100 mg/ml · solución inyectable en jeringa precargada · Glaxosmithkline Trading Services LimitedSame brand
ExdensurEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
ExdensurCroatiaSame brand
ExdensurItaly · Soluzione iniettabile in penna pre-riempita · Glaxosmithkline Trading Services LimitedSame brand
EXDENSUR 100 mg oplossing voor injectie in een voorgevulde penNetherlands · Oplossing voor injectie · GlaxoSmithKline Trading Services LimitedSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Depemokimab

Exdensur

100 MG / 1 ML SolutionCanadaMarketedAuthorised 17 Jul 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

EXDENSUR 100 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · GlaxoSmithKline Trading Services Limited

ExdensurUnited States · 100MG · injection · Glaxosmithkline LLC

ExdensurUnited States · 100MG/ML · Injection · GlaxoSmithKline LLC

DensurkoBrazil · Glaxosmithkline Brasil Ltda

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Depemokimab
Strength: 100 MG / 1 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 17 Jul 2026
Registration: DIN 02568934
Marketing authorisation holder: Glaxosmithkline INC
ATC code: R03DX12
Group: Respiratory system
Supply: PRESCRIPTION, SCHEDULE D